Search Results - "Schuhmacher, C"

PG 9.02 Is endosonography and laparoscopy essential before neoadjuvant therapy? by Schuhmacher, C

Get full text

Identification of Lead User Characteristics Driving the Quality of Service Innovation Ideas by Schuhmacher, Monika C., Kuester, Sabine

“…Research indicates that creative ideas provide the seed for successful service innovations. However, little attention has been paid to understanding idea…”
Get full text

The European Organization for Research and Treatment for Cancer (EORTC) strategy for quality assurance in surgical clinical research: Assessment of the past and moving towards the future by Tanis, E, Caballero, C, Collette, L, Verleye, L, den Dulk, M, Lacombe, D, Schuhmacher, C, Werutsky, G

“…Abstract Aims Quality assurance (QA) in a surgical trial must be planned and implemented from study development to completion. Elements of quality must be…”
Get full text

Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs) by Ronellenfitsch, Ulrich, Schwarzbach, Matthias, Hofheinz, Ralf, Kienle, Peter, Nowak, Kai, Kieser, Meinhard, Slanger, Tracy E, Burmeister, Bryan, Kelsen, David, Niedzwiecki, Donna, Schuhmacher, Christoph, Urba, Susan, van de Velde, Cornelis, Walsh, Thomas N, Ychou, Marc, Jensen, Katrin

“…Abstract Background Neoadjuvant chemotherapy improves prognosis of patients with locally advanced gastroesophageal adenocarcinoma. The aim of this study was to…”
Get full text

Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: A direct and adjusted indirect comparison meta-analysis by Kumagai, K, Rouvelas, I, Tsai, J.A, Mariosa, D, Lind, P.A, Lindblad, M, Ye, W, Lundell, L, Schuhmacher, C, Mauer, M, Burmeister, B.H, Thomas, J.M, Stahl, M, Nilsson, M

“…Abstract Several phase I/II studies of chemoradiotherapy for gastric cancer have reported promising results, but the significance of preoperative radiotherapy…”
Get full text

2200 TOPGEAR: A randomized phase M/MI trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer. Interim results from an international, intergroup trial of the AGITG/TROG/NCIC CTG/EORTC by Leong, T, Smithers, B.M, Michael, M, Gebski, V, Simes, J, Boussioutas, A, Miller, D, Zalcberg, J, O'Connell, R, Swallow, C, Darling, G, Wong, R, Schuhmacher, C, Lordick, F, Haustermans, K

Get full text

What frugal products are and why they matter: A cross-national multi-method study by von Janda, Sergej, Kuester, Sabine, Schuhmacher, Monika C., Shainesh, G.

“…In numerous industries, companies are challenged by increasing resource scarcity, severe waste problems, and the necessity to minimize the environmental impact…”
Get full text

Randomized controlled trial of ultrasonic dissection versus standard surgical technique in open left hemicolectomy or total gastrectomy by Wilhelm, D., Szabo, M., Glass, F., Schuhmacher, C., Friess, H., Feussner, H.

“…Background: Ultrasonic dissection devices have been designed for use in open surgery but it is not certain how they compare with standard surgical techniques…”
Get full text

64. EORTC-1203: Integration of trastuzumab, with or without pertuzumab, into perioperative chemotherapy of HER-2 positive stomach cancer: INNOVATION EudraCT number 2014-000722-38; NCT02205047 by Wagner, A.D, Kang, Y.K, Van Dieren, J, Mauer, M, Grabsch, H, Caballero, C, Kataoka, K, Atasoy, A, Cho, J.Y, Mohler, M, Roth, A, Salto-Tellez, M, Langer, R, Schuhmacher, C, Van Sandick, J, Van Grieken, N, Lordick, F

Get full text

Antimicrobial Stewardship with and without Infectious Diseases Specialist Services to Improve Quality-of-Care in Secondary and Tertiary Care Hospitals in Germany: Study Protocol of the ID ROLL OUT Study by Zimmermann, Nicole, Allen, Rebekka, Fink, Geertje, Först, Gesche, Kern, Winfried V., Farin-Glattacker, Erik, Rieg, Siegbert

“…Background Antimicrobial stewardship (AMS) programs aim to secure the rational prescription of antibiotics through implementing department- or hospital-level…”
Get full text

How Pricing Teams Develop Effective Pricing Strategies for New Products by Feurer, Sven, Schuhmacher, Monika C., Kuester, Sabine

“…Companies increasingly rely on pricing teams to master the complexity of pricing a new product. However, little is known about how firms should design such…”
Get full text

Evaluating Affordance-Based Opportunities: A Conjoint Experiment of Corporate Venture Capital Managers’ Decision-Making by Ademi, Petrit, Schuhmacher, Monika C., Zacharakis, Andrew L.

“…We integrate opportunity evaluation reasoning with affordance theory to develop a nuanced theoretical model of action orientation in entrepreneurial…”
Get full text

Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleeding by Schuhmacher, Christoph, Pratschke, Johann, Weiss, Sascha, Schneeberger, Stefan, Mihaljevic, André L, Schirren, Rebekka, Winkler, Michael, Emmanouilidis, Nikos

“…Continuous bleeding after using conventional hemostatic methods involving energy, sutures, or clips, is a serious and costly surgical complication. Many…”
Get full text

Appetizer or Main Course: Early Market vs. Majority Market Go‐to‐Market Strategies for Radical Innovations by Schuhmacher, Monika C., Kuester, Sabine, Hultink, Erik Jan

“…Different views exist in the literature regarding which adopter group to target with a go‐to‐market strategy: early market consumers or consumers in the…”
Get full text

Sectoral Heterogeneity in New Service Development: An Exploratory Study of Service Types and Success Factors by Kuester, Sabine, Schuhmacher, Monika C., Gast, Barbara, Worgul, Andreas

“…The service industry is of fundamental relevance for the economies of industrialized countries, as the service industry produces the highest growth in the…”
Get full text

Comparing the incomparable? How consumers judge the price fairness of new products by Kuester, Sabine, Feurer, Sven, Schuhmacher, Monika C., Reinartz, Dominik

“…The present article explores price fairness perceptions in the specific setting of new product launch prices. In this context, the process of forming price…”
Get full text

Reversing Gears: Inverting the Innovation-Flow Paradigm with Reverse Innovation by von Janda, Sergej, Schuhmacher, Monika C., Kuester, Sabine

“…Addressing resource-constrained customers in emerging markets presents business opportunities beyond local market borders. Multinational corporations can…”
Get full text

Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection by Fink, U, Schuhmacher, C, Stein, H J, Busch, R, Feussner, H, Dittler, H J, Helmberger, A, Böttcher, K, Siewert, J R

“…Despite extensive resection and systematic lymphadenectomy the prognosis of patients with locally advanced gastric carcinoma remains poor. The effect of…”
Get more information

PCN26 - Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC): A Mixed Treatment Comparison (MTC) by Paracha, N, Irahara, N, Schuhmacher, C

Get full text

Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC): A Mixed Treatment Comparison (MTC) by Paracha, N, Irahara, N, Schuhmacher, C

“…OBJECTIVES: T-DM1 is approved for the treatment of MBC in patients previously treated with trastuzumab+taxane. We compared the clinical effectiveness of T-DM1…”
Get full text